Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

about

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

Item

http://www.wikidata.org/entity/Q54937991

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@en

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@nl

type

Item

label

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@en

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@nl

prefLabel

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@en

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@nl

P1476

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

@en

P2093

Afshin Habibzadeh

http://www.w3.org/2001/XMLSchema#string

Effat Irani Jam

http://www.w3.org/2001/XMLSchema#string

Hossein Doustkami

http://www.w3.org/2001/XMLSchema#string

Saeed Sadeghieh Ahari

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Clinical and economic studies of eptifibatide in coronary stenting

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery

Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Societ

2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideli

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2-Hour Infusion in High-Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention.

Panoptic total cardiovascular risk prediction using all predictors versus optimized risk assessment using variable subsets.

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

P304

107-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/CR675W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755628

http://www.w3.org/2001/XMLSchema#string

P932

5942240

http://www.w3.org/2001/XMLSchema#string